Clinical Study of Azacitidine Combined With Ruxolitinib in the Treatment of Higher-risk MDS/MPN

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Study of Azacitidine Combined With Ruxolitinib in the Treatment of Higher-risk MDS/MPN	myelodysplastic/myeloproliferative neoplasm	Recruiting	Phase 2	2023-04-18		NCT05817955

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Jiangsu University	7
The Affiliated Jiangning Hospital of Nanjing Medical University	9
The First Affiliated Hospital with Nanjing Medical University	319
The Second Hospital of Nanjing Medical University	37

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Nanjing Medical University	Nanjing	China	15

Clinical trials